The short version of Methionine oxidation fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-24 and is reviewed periodically as new material appears.
The compound is registered in Russia as a pharmaceutical product, most commonly formulated as a nasal solution, and has been used in that setting since the 1990s. Outside that jurisdiction it is generally handled as a research chemical rather than an approved medicine. Regulatory status therefore differs sharply between countries, and material sold internationally may not correspond to the Russian pharmaceutical formulation. Documentation with commercial samples is typically limited to a certificate of analysis covering purity and identity, not clinical status or local legal classification.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro tripeptide, an addition intended to slow enzymatic breakdown. The molecular formula is C37H51N9O10S and the molecular mass is approximately 814 daltons. In the literature it is often described as an ACTH(4-10) analog, although that label reflects a naming convention as much as a precise structural relationship. The compound was developed in Russia and remains most closely associated with that research tradition.
Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.
Stability depends heavily on physical state. Lyophilized powder held dry, cold and dark retains its content over long periods, whereas dissolved peptide begins to change within days at room temperature. The most cited degradation route is oxidation of the methionine residue, which converts the peptide to a sulfoxide form that elutes differently on chromatography. Hydrolysis of amide bonds and adsorption onto container walls contribute smaller losses. Buffers that exclude oxygen from the headspace slow the oxidation pathway, but no single condition prevents all change indefinitely.
Practical handling follows from those properties. Bulk material is best divided into single-use portions soon after receipt, because each thaw exposes the whole container to moisture and temperature cycling. Vials should be allowed to reach room temperature before opening to prevent condensation on the powder. Low-binding plasticware reduces loss of dilute solutions, and sterile filtration is used when a preparation must remain free of microbial growth. Records of batch number, reconstitution date and storage history are what allow a later analytical result to be interpreted meaningfully.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C37H51N9O10S | Contains one methionine sulfur atom |
| Molecular mass | Approximately 814 Da | Consistent with a seven-residue peptide |
| Appearance | White to off-white powder | Typical lyophilized form |
| Solubility | Freely soluble in water | Also soluble in dimethyl sulfoxide |
| Typical storage | -20 °C, desiccated | Limits methionine oxidation |
Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.
Common degradation pathways include oxidation of the methionine side chain, hydrolysis of the peptide backbone, and aggregation under unfavourable pH or concentration. Stability studies typically monitor the main peak by chromatography and report total related substances as a percentage. Because no official monograph exists, acceptance criteria vary between laboratories, and reported purity values are not directly comparable across suppliers. Analysts therefore document the method, column, and detection wavelength alongside each result, and open questions remain about how much biological activity the oxidised forms retain.
Solid semax is typically supplied as a lyophilised powder that is hygroscopic and sensitive to moisture, light, and repeated temperature cycling. Long-term storage of the dry peptide is generally recommended at approximately -20 degrees Celsius, while shorter working periods may use refrigeration at 2 to 8 degrees Celsius. Vials should remain tightly closed and desiccated when brought to room temperature, because condensation can damage the material before it is weighed. Dividing a batch into aliquots is preferable to thawing one container repeatedly.
=== Heritage Conservation Areas === Holyhead has three officially designated Conservation Areas. Holyhead Central Conservation Area covers the historic Old Town core that developed around the Roman Fort. Holyhead Beach Conservation Area in located in the Newry promenade area, and Holyhead Mountain Conservation Area is located north of the village of Llaingoch.
== Applications == Safrole is a member of the methylenedioxybenzene group, of which many compounds are used as insecticide synergists; for example, safrole is used as a precursor in the synthesis of the insecticide piperonyl butoxide. Safrole is also used as a precursor in the synthesis of the drug ecstasy (MDMA, 3,4-methylenedioxymethamphetamine). Before safrole was banned by the US FDA in 1960 for use in food, it was used as a food flavor for its characteristic 'candy-shop' aroma. It was used as an additive in root beer, chewing gum, toothpaste, soaps, and certain pharmaceutical preparations. Safrole exhibits antibiotic and anti-angiogenic functions.
==== Other expansion formats explored ==== After the expansion to 48 teams was approved on January 10, 2017, it was initially decided that the tournament would include 16 groups of 3 teams, with the top two teams of each group progressing to a round of 32. This format would have included 80 matches in total, with the maximum number of matches per team remaining at seven, although each team would have played one fewer group match than in the 2022 tournament. The tournament would still have been completed within 32 days. This format was chosen over three alternatives involving 40 to 48 teams, 76 to 88 matches, and a minimum of 1 to 4 matches per team. Critics of this format argued that the use of three-team groups with two teams progressing significantly increased the risk of collusion between teams. This prompted FIFA to suggest that penalty shootouts could be used to prevent draws in the group stage, although even then some risk of collusion would remain, as it was possible for the two teams playing the last group match to engineer a circle of death result that would allow both of them to qualify. The tournament format was finalized in 2023, with an announcement that there would be 12 groups of 4 teams.
=== Columbia University: 1933-1934 === In April 1933, Schoenheimer emigrated to the United States in response to the Nazi regime's policy for the dismissal of Jewish faculty in universities. He was offered work at Columbia University as an assistant professor, where he continued his research on metabolism and cholesterol synthesis, alongside Walter M. Sperry and David Rittenberg. In 1933, Germany entered a political crisis and saw the rise of Hitler and the Nazi Party, which led Schoenheimer into emigrating to the United States. Schoenheimer had Jewish heritage which he was conscious of despite his Family having converted to Christianity. Schoenheimer had joined a Jewish Youth Movement and was actively involved in the Zionist Organisation following WW1. Due to the situation in Germany at the time and the Nazi Policy dismissing Jewish faculty, Schoenheimer was unlikely to remain living in Germany. Ludwig Kast was informed of this situation and contacted U.S universities, Cornell and Columbia on behalf of Schoenheimer. Hans T. Clarke, the Chairman of the Biological Chemistry Department at the University of Columbia, invited Schoenheimer to work at the university. He began work in the Department of Biological Chemistry as a research assistant. The Josiah Macy Foundation provided his salary and research support whilst he worked at Columbia. At Columbia Schoenheimer was among others that shared similar interests in Biochemistry and wanted it to move in the direction of organic chemistry.
Sources: en.wikipedia.org
=== United States === In the 2 July 2026 issue of Federal Register (21 FR 1308), the federal government of the United States (through the Administrator of the Drug Enforcement Administration) issued a notice of intent to publish a temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16) under Schedule I of the Controlled Substances Act. On August 25, 2026, the DEA placed MGM-15 in Schedule I through an emergency temporary scheduling order, making unauthorized possession, manufacture, and distribution illegal.
== History == The US Food and Drug Administration (FDA) approved copper histidinate based on evidence from two clinical trials, in which efficacy and safety were evaluated in 66 and 129 participants with Menkes disease, respectively, treated with copper histidinate. The trials were conducted at a single site in the United States. Copper histidinate was evaluated in 129 participants with Menkes disease receiving three years of copper histidinate treatment in two open-label, single-arm clinical trials (trial 1, NCT00001262 and trial 2, NCT00811785). Survival data from participants treated with copper histidinate in these two trials were compared to survival data from an untreated contemporaneous external control cohort as collected under a protocol amendment of trial 2. In both trials, participants aged younger than one year of age received 1.45 mg of copper histidinate given subcutaneously twice a day until they reached one year of age; participants aged one year of age and older received 1.45 mg of copper histidinate subcutaneously once daily for up to three years. Safety data were evaluated in 129 participants receiving copper histidinate in trial 1 and trial 2. There were insufficient safety data in the control group for evaluation.
However, he assured that the United States would oppose Peru if it had Cuban support, though that remained speculative. Meanwhile, Pinochet carried out border mining to prevent an invasion; For this, some 180,000 anti-tank and anti-personnel mines were installed on all the borders of Chile between 1975 and 1990, in addition to promoting the development of chemical weapons to use them against the Peruvian Army. On the other hand, the Ecuadorian military, which had received material support from Pinochet (now as senator for life in Chile) during the Cenepa War with Peru in 1995, they honored him with a series of decorations. In addition, some historiographical currents of Chilean origin, have fallen into some anti-Peruvian biases when analyzing historical events of continental and South American impact, for example, the works of the Chilean Gonzalo Bulnes: Historia de la expedición libertadora del Perú (1817–1822), and Bolívar en el Perú: Últimas campañas de la independencia del Perú, are described by Raúl Porras Barrenechea as "anti-Peruvian" for tending to emphasize foreign intervention in the Independence of Peru and belittling Peruvian perspectives about the event. Also, through the analysis of Chilean history school textbooks in 2010, Parodi proposed a model to understand how the relations between Chile with Peru and Bolivia are perceived in national education, by which Chile assumes the subordinate role and Peru and Bolivia, the role of subordinate nations.
==== Green ==== Feces can be green due to having large amounts of unprocessed bile in the digestive tract and strong-smelling diarrhea. This can occasionally be the result from eating liquorice candy, as it is typically made with anise oil rather than liquorice herb and is predominantly sugar. Excessive sugar consumption or a sensitivity to anise oil may cause loose, green stools. It can also result from consuming excessive amounts of blue or green dye.
Other forms are due to different diseases causing overabundant or abnormal protein production – such as with overproduction of immunoglobulin light chains (termed AL amyloidosis), or with continuous overproduction of acute phase proteins in chronic inflammation (which can lead to AA amyloidosis). About 60 amyloid proteins have been identified so far. Of those, at least 36 have been associated with a human disease. All amyloid fibril proteins start with the letter "A" followed by the protein suffix (and any applicable specification). See below for a list of amyloid fibril proteins which have been found in humans:
Sources: en.wikipedia.org
It is registered as a pharmaceutical product in Russia, where it is typically supplied as a nasal solution. In most other countries it is not an approved drug and is traded as a research chemical instead. Approval status depends entirely on the jurisdiction involved.
Most published work uses intranasal administration, matching the route of the registered Russian formulation. Some animal experiments use intravenous or intraperitoneal injection. The route matters because the intact peptide is cleared rapidly from blood, so exposure differs between methods.
A purity value describes the share of the powder accounted for by the target peptide, usually by high-performance liquid chromatography. It does not confirm that the sequence is correct, which requires mass spectrometry or amino acid analysis. Purity and identity are separate checks.
Suppliers normally quote a percentage of total chromatographic peak area, most often from reversed-phase HPLC. That figure says nothing about what the remaining percentage contains, and it depends on the detection wavelength used. A mass spectrometry result is a separate and stronger check on identity.